Apteryx Imaging vs Labcorp

Side-by-side comparison of AI visibility scores, market position, and capabilities

Labcorp leads in AI visibility (79 vs 36)
Apteryx Imaging logo

Apteryx Imaging

EmergingDental Practice Technology

Dental Imaging Software

Dental imaging and practice management software for small and mid-size dental practices, offering digital radiography, patient records, and imaging workflow tools. Based in Akron, Ohio.

AI VisibilityBeta
Overall Score
D36
Category Rank
#501 of 596
AI Consensus
86%
Trend
stable
Per Platform
ChatGPT
37
Perplexity
32
Gemini
36

About

Apteryx Imaging is an Akron, Ohio-based dental technology company specializing in digital radiography software and imaging workflow tools for dental practices. The company developed XrayVision, a widely used dental imaging software platform that supports intraoral sensors, phosphor plate systems, and panoramic units from multiple hardware manufacturers. This hardware-agnostic approach differentiates Apteryx from imaging vendors that bundle proprietary sensor hardware with locked-in software.\n\nXrayVision integrates with a broad range of practice management and electronic dental record systems, allowing practices to retain their existing clinical software while upgrading or adding digital imaging hardware from various manufacturers. The platform includes tools for image acquisition, enhancement, annotation, and archiving, as well as periodontal charting and patient communication features that extend its utility beyond pure radiography management.\n\nApteryx has been acquired by Carestream Dental, becoming part of a broader dental imaging portfolio. Prior to the acquisition, Apteryx built a loyal installed base among independent dental practices and small group practices that valued the flexibility of working with multiple sensor brands rather than being locked into a single manufacturer's ecosystem. The company's strength in open imaging platform integrations has historically made it popular with practices that prioritize interoperability and want the freedom to choose imaging hardware independently from their software platform.

Full profile
Labcorp logo

Labcorp

LeaderHealthcare Tech

Enterprise

Burlington NC clinical laboratory services (NYSE: LH) ~$13.1B FY2024 revenue; Fortrea CRO spun off 2023, 2000+ PSC network, specialty oncology molecular testing competing with Quest Diagnostics.

AI VisibilityBeta
Overall Score
B79
Category Rank
#31 of 596
AI Consensus
68%
Trend
stable
Per Platform
ChatGPT
74
Perplexity
82
Gemini
73

About

Laboratory Corporation of America Holdings (Labcorp) is a Burlington, North Carolina-based clinical laboratory and life sciences company — publicly traded on the New York Stock Exchange (NYSE: LH) as an S&P 500 Health Care component — providing diagnostic laboratory testing services for physicians, hospitals, health systems, and patients across the United States and internationally, and providing drug development laboratory services (biopharmaceutical clinical trial laboratory support) through approximately 60,000 employees. In fiscal year 2024, Labcorp reported revenues of approximately $13.1 billion from the Diagnostics segment — following the June 2023 separation of its Drug Development segment as Fortrea Holdings (NASDAQ: FTRE), an independent public company providing CRO (contract research organization) services to pharmaceutical and biotech clients. CEO Adam Schechter has focused the post-Fortrea Labcorp on the pure-play diagnostics business: clinical testing across 6,000+ test menu items (routine blood work, specialty genetic testing, toxicology, and anatomic pathology) processed at Labcorp's 2,000+ patient service centers and sent to regional and specialty reference laboratories for results reporting to ordering physicians. The Labcorp consumer-direct testing initiative (at-home specimen collection kits for STI testing, COVID testing, and other direct-to-consumer tests ordered at labcorp.com without physician referral) expands beyond the traditional physician-ordered testing model to capture the growing consumer health testing market. Labcorp's specialty testing portfolio (oncology genomic profiling, rare disease genetic panels, prenatal cell-free DNA testing, advanced cardiac biomarker panels) generates higher revenue per requisition than routine chemistry and hematology panels — driving mix shift toward specialty and molecular testing revenue.

Full profile

AI Visibility Head-to-Head

36
Overall Score
79
#501
Category Rank
#31
86
AI Consensus
68
stable
Trend
stable
37
ChatGPT
74
32
Perplexity
82
36
Gemini
73
35
Claude
85
32
Grok
75

Key Details

Category
Dental Imaging Software
Enterprise
Tier
Emerging
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only Apteryx Imaging
Dental Imaging Software

Integrations

Only Labcorp
Labcorp is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.